Stock Events

Coloplast AS 

€100
4
+€0.48+0.48% Today

Statistics

Day High
100
Day Low
99.72
52W High
-
52W Low
-
Volume
30
Avg. Volume
-
Mkt Cap
23.97B
P/E Ratio
37.95
Dividend Yield
2.71%
Dividend
2.71

Upcoming

Dividends

2.71%Dividend Yield
May 23
€0.67
Dec 22
€2.02
May 22
€0.67
Dec 21
€1.88
May 21
€0.67

Earnings

9NovExpected
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
0
0.03
0.06
0.1
Expected EPS
0.095
Actual EPS
0

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CBHD.F. It's not an investment recommendation.

About

Coloplast A/S develops and markets intimate healthcare products and services worldwide. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as SpeediCath catheters that offer catheterization for both genders; Peristeen, an anal irrigation system for controlled emptying of the bowels; and Conveen Active urine bags. In addition, it provides wound care products, such as foam dressings under the Biatain brand and hydrocolloid dressing under the Comfeel brand, as well as skin care products, such as bathing and cleansing products, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
Show more...
CEO
Mr. Kristian Villumsen
Employees
12500
Country
DK
ISIN
DK0060448595
WKN
000A1KAGC

Listings